Health Care

Commentary

U.S. Bureaucrats Are An Impediment To Pandemic Recovery

Late last month, the Biden administration announced a new initiative to lower the cost of at-home Covid-19 tests and make them more widely available. It’s long past time. Throughout the pandemic, bureaucratic sclerosis has proven the American regulatory apparatus to be an impediment to fighting Covid-19—not to mention future public health threats. ...
Blog

Get Ready for Another Big California Spending Spree

Governor Newsom let the cat of the bag recently in an interview at the Milken Institute’ annual conference – California is going to see another of what he calls a “historic budget surplus” next year. The Sacramento Bee reports that “in addition a surplus for next year’s budget, Newsom said ...
Commentary

Democrats Abandon US Patients to Rescue Drug-Pricing Reform

Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
Health Care

NEW BRIEF: U.S. Patients Could Save Up to $5.8 Billion Through Competition from Humira and Enbrel Biosimilars

Policies that promote biosimilar competition have the potential to save U.S. patients up to $5.8 billion collectively if biosimilars to Humira and Enbrel grow in market share, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute, a California-based, free-market ...
Commentary

Biden’s new plan isn’t any better for your health

Last week, President Joe Biden unveiled a new social spending framework that omitted many of the healthcare provisions Democrats have been calling for. One provision that has survived is a massive and wasteful expansion of Obamacare . In March, Congress made federal tax credits available to those shopping for coverage on the exchanges with ...
Blog

Getting the Drug Spending Facts Right

In a typical rant, Senator Sanders claimed in a September 15th press release that “at a time when the drug companies are charging us by far the highest prices in the world, Congress must demand that Medicare negotiate prices with this extremely greedy and powerful industry.” The Senator clearly misunderstands ...
Business & Economics

Jon Miltimore – The Push for Socialism and Economic Restrictions in the Name of the Pandemic

Enjoy this recent conversation between Jon Miltimore of the Foundation for Economic Education and PRI’s Evan Harris for our Young Leaders Circle Speaker Series.  They discuss socialism, progressive politics, economic news, and the latest pandemic restrictions.
Commentary

Single-Payer Will Worsen Healthcare Workers’ Plight

Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Coronavirus

Dr. Henry Miller Explains COVID Rapid Tests with Lars Larson

Dr. Henry Miller, M.S., M.D., joins the nationally-syndicated Lars Larson Show to talk about how the U.S. Food and Drug Administration, FDA, blocked a crucial test, the rapid response antigen test, to help with COVID-19 testing. The test is an at-home test that takes roughly 20 minutes. Dr. Miller explains ...
Blog

Local Government COVID-19 Relief Funds Bonuses for Government Workers

Earlier this year, Congress enacted $350 billion in “state and local government aid” as part of the so-called American Rescue Plan.  This is in addition to receiving $150 billion in relief in the first federal Coronavirus Relief Fund enacted in March 2020, and which according to a recent estimate, state ...
Commentary

U.S. Bureaucrats Are An Impediment To Pandemic Recovery

Late last month, the Biden administration announced a new initiative to lower the cost of at-home Covid-19 tests and make them more widely available. It’s long past time. Throughout the pandemic, bureaucratic sclerosis has proven the American regulatory apparatus to be an impediment to fighting Covid-19—not to mention future public health threats. ...
Blog

Get Ready for Another Big California Spending Spree

Governor Newsom let the cat of the bag recently in an interview at the Milken Institute’ annual conference – California is going to see another of what he calls a “historic budget surplus” next year. The Sacramento Bee reports that “in addition a surplus for next year’s budget, Newsom said ...
Commentary

Democrats Abandon US Patients to Rescue Drug-Pricing Reform

Just a few days ago, it appeared that Democrats had given up on including prescription drug pricing reforms in their massive spending bill. But not anymore. In an eleventh-hour turn of events, congressional Democrats this week resurrected their long-standing desire to levy government price controls on prescription drugs. If lawmakers successfully deploy their latest ...
Health Care

NEW BRIEF: U.S. Patients Could Save Up to $5.8 Billion Through Competition from Humira and Enbrel Biosimilars

Policies that promote biosimilar competition have the potential to save U.S. patients up to $5.8 billion collectively if biosimilars to Humira and Enbrel grow in market share, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute, a California-based, free-market ...
Commentary

Biden’s new plan isn’t any better for your health

Last week, President Joe Biden unveiled a new social spending framework that omitted many of the healthcare provisions Democrats have been calling for. One provision that has survived is a massive and wasteful expansion of Obamacare . In March, Congress made federal tax credits available to those shopping for coverage on the exchanges with ...
Blog

Getting the Drug Spending Facts Right

In a typical rant, Senator Sanders claimed in a September 15th press release that “at a time when the drug companies are charging us by far the highest prices in the world, Congress must demand that Medicare negotiate prices with this extremely greedy and powerful industry.” The Senator clearly misunderstands ...
Business & Economics

Jon Miltimore – The Push for Socialism and Economic Restrictions in the Name of the Pandemic

Enjoy this recent conversation between Jon Miltimore of the Foundation for Economic Education and PRI’s Evan Harris for our Young Leaders Circle Speaker Series.  They discuss socialism, progressive politics, economic news, and the latest pandemic restrictions.
Commentary

Single-Payer Will Worsen Healthcare Workers’ Plight

Healthcare workers are exchanging scrubs and gloves for signs and megaphones. In what’s been called “Striketober,” frontline staff are walking out of hospitals, emergency rooms, and doctor’s offices to insist on better pay, benefits, and hours. Earlier this month, Kaiser Permanente workers in California voted to authorize a strike over ...
Coronavirus

Dr. Henry Miller Explains COVID Rapid Tests with Lars Larson

Dr. Henry Miller, M.S., M.D., joins the nationally-syndicated Lars Larson Show to talk about how the U.S. Food and Drug Administration, FDA, blocked a crucial test, the rapid response antigen test, to help with COVID-19 testing. The test is an at-home test that takes roughly 20 minutes. Dr. Miller explains ...
Blog

Local Government COVID-19 Relief Funds Bonuses for Government Workers

Earlier this year, Congress enacted $350 billion in “state and local government aid” as part of the so-called American Rescue Plan.  This is in addition to receiving $150 billion in relief in the first federal Coronavirus Relief Fund enacted in March 2020, and which according to a recent estimate, state ...
Scroll to Top